Skip to main content
Back

DNA Sequencing Technologies and Applications in Genetics

Study Guide - Smart Notes

Tailored notes based on your materials, expanded with key definitions, examples, and context.

DNA Sequencing Technologies

Introduction to DNA Sequencing

DNA sequencing is a fundamental technique in genetics that determines the precise order of nucleotides within a DNA molecule. Modern sequencing technologies have revolutionized genetic research, enabling rapid and cost-effective analysis of entire genomes.

  • DNA Sequencing: The process of determining the nucleotide sequence of DNA.

  • Applications: Used in genomics, medical diagnostics, evolutionary biology, and personalized medicine.

DNA Sequencing

Next Generation Sequencing (NGS)

Next Generation Sequencing (NGS) refers to advanced sequencing technologies that allow simultaneous sequencing of millions of DNA fragments, surpassing traditional Sanger sequencing in speed and throughput.

  • Definition: NGS encompasses any modern sequencing technology that is not Sanger sequencing.

  • Key Features: High throughput, rapid sequencing, and ability to sequence multiple DNA molecules at once.

NGS – Next Generation Sequencing

Cost of NGS Sequencing

The cost of sequencing the human genome has dramatically decreased over the past two decades, making large-scale genomic studies feasible.

  • Historical Trend: Sequencing costs have dropped from millions of dollars to less than $1,000 per genome.

  • Impact: Enables widespread use in research and clinical settings.

Cost per Human Genome

NGS Sequencing Advances

Advances in NGS technology have increased the number of human genomes sequenced annually, reflecting improvements in speed, efficiency, and accessibility.

  • Annual Output: Modern instruments can sequence thousands to tens of thousands of genomes per year.

  • Technological Progress: Newer platforms offer higher throughput and lower costs.

Human Genomes Sequenced Annually 500,000 whole human genomes will be a game-changer for research into human diseases

NGS Sequencing Technology: Workflow and Instrumentation

NGS Workflow Overview

The typical workflow for sequencing a human tissue sample using NGS involves several key steps:

  1. DNA Isolation: Extract DNA from the tissue sample.

  2. Fragmentation: Break DNA into smaller pieces (~200-500 bp).

  3. Adapter Ligation: Add adapters to DNA fragments for identification and amplification.

  4. PCR Amplification: Amplify the DNA library.

  5. Attachment to Slide: Bind DNA fragments to a solid support (flow cell).

  6. Cluster Generation: Amplify DNA clusters by PCR.

  7. Sequencing by Synthesis: Use cycles of extension with reversible terminators to read DNA sequence.

  8. Data Analysis: Align sequences to reference genome and interpret results.

NGS Instrumentation: Flow Cells

Flow cells are specialized glass slides used in NGS platforms to hold DNA samples for simultaneous sequencing.

  • Structure: Typically contain multiple lanes for parallel sample processing.

  • Cluster Density: High density of DNA clusters enables massive parallel sequencing.

Flow cell NGS – Flow cells Illumina Flow Cell HiSeq Flow Cells HiSeq Flow Cells cluster density

NGS Sequencing Platforms

Several NGS platforms are available, each with varying throughput and read lengths.

  • MiniSeq, MiSeq, NextSeq, HiSeq 4000, HiSeq X Ten: Instruments differ in capacity, number of reads, and read length.

  • Illumina: Leading manufacturer of NGS platforms.

NGS Sequencing Platforms Illumina logo Illumina sequencing instrument

Comparison of DNA Sequencing Methods

Sequencing Methods Table

The following table compares Sanger, Roche 454, and Illumina sequencing methods based on template, sample preparation, read length, rate, and comments.

Method

Template, primer, and reaction

Sample preparation

Sequencing read

Approximate rate

Comments

Sanger dideoxy

Single DNA template, single primer per reaction

Purified product

Approximately 700 bp

One run in 20–150 minutes

Useful for single applications but impractical for large genomes

Roche 454

Thousands of DNA templates on beads in an oil emulsion for PCR

Fragmentation

Up to 700 bp

1 GB in 3 days, or 200–300 MB in 8 hours

Low reads quickly, but individual sequence runs more expensive

Illumina

Thousands of DNA templates anchored on a solid support for PCR

Fragmentation

50–300 bp

Up to 20 GB in 1–10 days

High yields with a low cost per sequence run, but can be more expensive to capture short reads and might require more DNA

Sequencing Methods Table

NGS Key Innovations

Technological Innovations in NGS

NGS technologies have introduced several innovations that enhance sequencing accuracy and efficiency.

  • High Resolution Photographic Detectors: Enable precise detection of fluorescent signals during sequencing.

  • Reversible Fluorescent Terminators: Allow repeated cycles of sequencing by synthesis, increasing throughput.

NGS Applications in Genetics and Medicine

Precision Medicine and Targeted Therapies

NGS enables molecular profiling, which is essential for precision medicine. This approach tailors treatments to individual genetic profiles, improving patient outcomes.

  • Traditional Therapies: Apply the same treatment to all patients, resulting in variable effectiveness.

  • Precision Medicine: Uses genetic information to customize therapy for each patient.

Targeted therapies help improve oncology patient outcomes Traditional therapies vs Precision medicine

Impact on Cancer Treatment

Personalized strategies based on NGS data can significantly improve survival rates for cancer patients compared to non-personalized approaches.

  • Biomarker-Guided Treatment: Selection of therapies based on genetic biomarkers increases effectiveness.

  • Survival Benefit: Personalized medicine adds months to overall survival in advanced cancer cases.

Medium overall survival: personalized vs not personalized

Development of Targeted Medicines

The development of targeted therapies for solid tumors has accelerated, with many drugs now available that target specific genetic alterations.

  • Genetic Biomarkers: Testing for actionable genetic alterations is routine in oncology patient management.

  • Timeline: Numerous targeted drugs have been introduced since 1997, each associated with specific genetic markers.

Available targeted medicines—solid tumors

Conclusion

DNA sequencing technologies, especially NGS, have transformed genetics by enabling rapid, cost-effective, and high-throughput analysis of genomes. These advances support precision medicine, improve disease diagnosis and treatment, and drive the development of targeted therapies. Understanding these technologies is essential for modern geneticists and healthcare professionals.

Pearson Logo

Study Prep